Top 5 Drug Type | Count |
---|---|
Small molecule drug | 62 |
Herbal medicine | 22 |
Antibody | 17 |
Hormone | 5 |
Enzyme | 4 |
Target |
Mechanism F10 stimulants [+1] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date08 Aug 2022 |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date31 Oct 2021 |
Mechanism F10 modulators [+3] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date02 Dec 2020 |
Start Date07 Apr 2024 |
Sponsor / Collaborator |
Start Date01 Apr 2024 |
Sponsor / Collaborator |
Start Date27 Mar 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Diazoxide ( KATP channels ) | Hypertension More | Approved |
Recombinant human erythropoietin(China Resources Angde) ( EPO receptor ) | Anemia More | Approved |
Lumefantrine | Malaria More | Approved |
Hydrochlorothiazide/Triamterene/Dihydralazine Sulfate/Reserpine ( NCC x Sodium channels x VMAT2 ) | Hypertension More | Approved |
Oxyphenbutazone ( COX ) | Rheumatoid Arthritis More | Approved |